The discovery of a gene mutation that causes glaucoma may lead to earlier detection of the disease.
According to a report in Nature Genetics, the mutation is common among Europeans – approximately six per cent carry two copies, putting them at 60 per cent greater risk of developing the disease than those who carry none.
Professor Andrew Lotery, from the University of Southampton, who has been involved in the international research project said: “To make progress in this disease, we need to better understand the basic biological processes which lead to glaucoma. By doing this, we can then start to develop better treatments.
“Our work in helping identify a novel gene and biological pathway for glaucoma is an important step forward in this respect.”
Professor Lotery’s laboratory team has identified a new genetic association in age-related macular degeneration, which is leading to novel clinical treatments. The work in glaucoma is expected to eventually have the same result.
